The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer - Wikidata - awgldk - TriplyDB

The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer

The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer

http://www.wikidata.org/entity/Q34956110

about

Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001 Targeting abnormal DNA repair in therapy-resistant breast cancers Estrogens and prostate cancer: etiology, mediators, prevention, and management.Shu-Gan-Liang-Xue Decoction Simultaneously Down-regulates Expressions of Aromatase and Steroid Sulfatase in Estrogen Receptor Positive Breast Cancer Cells Local adipocytes enable estrogen-dependent breast cancer growth: Role of leptin and aromatase.A patent review on the development of human cytochrome P450 inhibitors.Aromatase: Contributions to Physiology and Disease in Women and Men.Efficacy of abiraterone acetate in post-docetaxel castration-resistant prostate cancer.

P2860

Q24302773-493B4480-4C99-4E7A-AEBE-66E4F88F0E6D Q24605455-2F45C124-77F8-40F2-863B-BD0995F4CBA6 Q35196710-59233CBB-A022-444B-A7B9-A8B14F4414FD Q36654691-2F78F92D-14F4-48E2-83D8-8077634EA372 Q37129102-4F00C50A-F8C6-4CF3-82A1-B7F60AC08F3F Q38198706-49FE6AEB-220E-46A0-8FAF-03A67B9A3B3E Q38851015-F8EBB954-2FDF-45A9-BA7E-360BFC6D7AEE Q42964655-78393DC6-616B-48CA-B5F9-15CA8C1B026A

P2860

The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer

http://www.wikidata.org/entity/Q34956110

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer

@ast

The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer

@en

The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer

@nl

type

label

The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer

@ast

The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer

@en

The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer

@nl

prefLabel

The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer

@ast

The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer

@en

The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer

@nl

P1433

Q34956110-BA5A8432-776E-48EA-AACA-20E4B59D8314

P1476

Q34956110-834C88C1-329C-4DBF-8C2F-CE2E1EDFEB0E

P2093

Q34956110-362D79A9-5DE0-4633-88EA-2C489C0ABA54

Q34956110-38546649-1949-4BD8-85D0-EEE000BF1BDA

Q34956110-DC9055B9-969F-4E08-BD3E-EA2CCA8F4C75

P2860

Q34956110-008DCA6C-C7AD-45AB-AAA6-4B78E35B5FD3

Q34956110-009BAD89-142A-4006-BF9B-8ACA8EBAFCB2

Q34956110-02A2417C-DB82-46B1-A8FA-B98E7B93B21D

Q34956110-05C52D85-212A-4F3F-A816-0C0192AA4F98

Q34956110-0C8C4578-E79D-44F9-B87A-A673BC0848F3

Q34956110-14C28EF7-BBE4-4CD9-B8CC-153AF6465D9E

Q34956110-1A70862C-02AB-4EC6-956F-07AE11F295BB

Q34956110-1D402BA2-34CF-4554-ADEA-45D1CEA9B327

Q34956110-2060F8A5-ED31-4E86-AC69-C0568063F748

Q34956110-2A1D65BE-BCE5-4462-BECD-11454BD8086D

P304

Q34956110-1D70AEFD-740D-4869-A233-431E215375F1

P31

Q34956110-001C30FB-B82F-461D-8086-D532BA48D47E

P356

Q34956110-C936315C-7424-4DCB-AC49-D42A5E399342

P433

Q34956110-0D5EEE79-05DE-4EE7-8D41-11F2CC72A477

P478

Q34956110-0A459E05-907A-42DB-A397-D1FE0D6FF442

P50

Q34956110-0D8CFF7A-7FB4-49CE-91A9-3E11E19A8B4C

Q34956110-320448ED-80AC-4026-8C55-79509D6F34A0

P577

Q34956110-36CC3F37-61E4-4981-BB55-1291A1D45FEC

P5875

Q34956110-FBD025D7-B108-4D16-BDE9-AC9B9AC9A56D

P698

Q34956110-D2369652-4EC4-4803-855F-8490C0E6D611

P932

Q34956110-DEDFC9F1-5EEE-4F16-9DEC-57CE2063DB53

P356

J.UROLONC.2008.07.036

P1433

Urologic Oncology

P1476

The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer

@en

P2093

Angela Brodie

http://www.w3.org/2001/XMLSchema#string

Luciana Furtado Macedo

http://www.w3.org/2001/XMLSchema#string

T Sean Vasaitis

http://www.w3.org/2001/XMLSchema#string

P2860

Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer

Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma.

Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase.

Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.

Inhibitors of 17alpha-hydroxylase/17,20-lyase (CYP17): potential agents for the treatment of prostate cancer.

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.

Aromatase activity in adipose tissue from breast quadrants: a link with tumour site.

P304

53-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.UROLONC.2008.07.036

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23708473

http://www.w3.org/2001/XMLSchema#string

P698

19111799

http://www.w3.org/2001/XMLSchema#string

P932

3090255

http://www.w3.org/2001/XMLSchema#string